In today's first round match-up of The Motley Fool Better-Buy Tournament, Sirius XM squares off against Sanofi in a battle to determine which stock is the better buy now. The 64-company tournament pits two Motley Fool analysts against each other as they make the case for their stocks, with the winner determined by you, the readers.
With the recent breaking news of John Malone dropping his bid for Sirius XM (SIRI -0.94%), long-term shareholders have reason to cheer: This lucrative business will continue to monopolize the satellite radio space, and shareholders can participate directly. At 25 million paid subscribers and growing, Sirius should continue to leverage its massive user base to drive increased profits. With $0.17 of every sales dollar flowing through as free cash, and the ability to determine its own destiny, Motley Fool analyst Michael Finarelli believes Sirius is a great way to gain exposure in this cash-rich market.
Motley Fool analyst Max Macaluso makes the case for Sanofi (SNY 0.68%), one of the biggest pharma companies in the world, to move on to the next round. While the stock has trailed the broader market lately, Max believes this company's diversified portfolio, long-term strategy, and robust drug development pipeline are key drivers going forward. Its attractive valuation and robust dividend also make this a stock that investors should keep on their radar.
Watch these analysts square off in the video below, and then vote for a winner. Then check out the other companies in the Motley Fool Better-Buy Bracket.
This year's winning stock?
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report, "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.
Cast your vote in the poll below the video!
